Source: Health Products Regulatory Authority (IE) Revision Year: 2020 Publisher: Evolan Pharma AB, PO Box 120, 182 12 Danderyd, Sweden
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Arterial leg ulcers.
If the outer bandage is inappropriate or the stocking is not changed with sufficient frequency it can cause the stocking to dry out.
None known.
There is no evidence to suggest Zipzoc should not be used during pregnancy or lactation.
It is unlikely to have an effect.
Very rare: Application site pain
Very rare: Oedema
Very rare: Application site folliculitis
Very rare: Erythema.
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance, Website: www.hpra.ie.
Not applicable.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
